LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

80.99 +2.03 (+2.57%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about LeMaitre Vascular, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Sell In May And Go Away? – April Dividend Income Report ↗

May 27, 2024

The “Sell in May and Go Away” adage is wrong for most investors.

Via Talk Markets

LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78 ↗

April 30, 2024

On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.

Via Investor's Business Daily

Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know ↗

February 28, 2024

Via Benzinga

Recap: LeMaitre Vascular Q4 Earnings ↗

February 27, 2024

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

A Preview Of LeMaitre Vascular's Earnings ↗

February 26, 2024

Via Benzinga

5 Analysts Have This to Say About LeMaitre Vascular ↗

October 23, 2023

Via Benzinga

Recap: LeMaitre Vascular Q1 Earnings ↗

May 02, 2023

Via Benzinga

Buy This Under-the-Radar Stock for Dividend Growth ↗

March 11, 2023

This specialty medical device maker treats its shareholders well.

Via The Motley Fool

Sidoti Events, LLC's Virtual December Small-Cap Conference

December 05, 2023

Via ACCESSWIRE

Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating ↗

September 06, 2023

Oppenheimer has initiated coverage on LeMaitre Vascular Inc (NASDAQ: LMAT) with an Outperform rating and a

Via Benzinga

Looking for Dividend Growth? Buy This Little-Known Healthcare Stock ↗

September 01, 2023

The healthcare company's dividend has soared in recent years.

Via The Motley Fool

2 Healthcare Stocks That Could Help Make You a Fortune ↗

August 26, 2023

These companies did well for shareholders over the last 10 years and have the potential to keep the growth going.

Via The Motley Fool

Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year ↗

August 23, 2023

Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year.

Via Investor's Business Daily

Is This Small-Cap Dividend Stock a Buy? ↗

January 13, 2023

LeMaitre Vascular isn't well-known to investors. But vascular surgeons do know the company well.

Via The Motley Fool

Is This Underfollowed Dividend Stock a Buy? ↗

November 23, 2022

The medical device maker flies under the radar of most investors.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗

September 06, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023 ↗

August 03, 2023

Via Benzinga

Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday ↗

August 03, 2023

Needham raised the price target for Extreme Networks, Inc. (NASDAQ: EXTR) from $30 to $35. Needham analyst Alex Henderson maintained a Buy rating. Extreme Networks shares fell 1.7% to $29.70 in...

Via Benzinga

3 Micro-Cap Stocks to Buy Now for Gigantic Growth Potential ↗

June 28, 2023

The smallest stocks have been trailing their larger counterparts. Here are three top micro-cap stocks to ride the asset class' resurgence.

Via InvestorPlace

Beat the Dow Jones With This Unstoppable Dividend Stock ↗

June 19, 2023

The wealth created by this medical devices company for its investors over the past decade far exceeds what the Dow Jones generated.

Via The Motley Fool

Sidoti Events, LLC's Virtual June Small-Cap Conference

June 13, 2023

Via ACCESSWIRE

Is This Healthcare Stock a Buy for Dividend Growth Investors? ↗

May 17, 2023

This medical device maker has crushed the S&P 500 index in the past 10 years.

Via The Motley Fool

Why Shares of LeMaitre Vascular Are Up Wednesday ↗

May 03, 2023

LeMaitre announced first-quarter earnings and guidance numbers.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023 ↗

May 03, 2023

Via Benzinga

The Best Dividend Achievers ↗

April 22, 2023

The Dividend Achievers show a minimum of 10 consecutive years with a dividend increase. Here are some of the top Dividend Achievers from 5 different sectors.

Via Talk Markets

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 21, 2023

It's time for a dive into the latest stock market happenings with the biggest pre-market stock movers worth watching on Friday!

Via InvestorPlace

Income Investors: These 2 Stocks Have Quadrupled Their Dividend Payouts Over the Past 10 Years ↗

April 06, 2023

These two stocks have generated massive dividend growth for shareholders in the last decade.

Via The Motley Fool

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.